Huntsville, AL, United States of America

Michael David Bentley

Average Co-Inventor Count = 3.4

ph-index = 20

Forward Citations = 2,379(Granted Patents)

Forward Citations (Not Self Cited) = 1,876(Sep 21, 2024)

DiyaCoin DiyaCoin 4.60 

Inventors with similar research interests:


Location History:

  • Casselberry, FL (US) (1994)
  • Hunstville, AL (US) (2013 - 2014)
  • Huntsville, AL (US) (1999 - 2024)


Years Active: 1994-2025

where 'Filed Patents' based on already Granted Patents

133 patents (USPTO):
15 patents (CIPO):

Title: Michael David Bentley: A Pioneer in Oligomer-Corticosteroid Conjugates and Polymer Derivatives

Introduction:

In the world of pharmaceutical innovations and polymer research, Michael David Bentley has made significant contributions. With a strong focus on creating chemically modified corticosteroids and polymeric reagents, Bentley's work has revolutionized drug delivery systems and polymer-active agent conjugation. This article sheds light on Bentley's latest patents, career highlights, notable collaborations, and his significant contributions to the field.

Latest Patents:

Michael David Bentley has an impressive portfolio of 125 patents, showcasing his talent as an inventor and innovator. Two of his recent noteworthy patents include:

1. Oligomer-Corticosteroid Conjugates: Bentley's invention involves the chemical modification of corticosteroids through covalent attachment of a water-soluble oligomer. This modification results in reduced biological membrane crossing rates, offering potential benefits in drug administration routes. Such advancements can significantly impact drug efficacy and patient outcomes.

2. Polymer Derivatives with Atom Arrangements: In this patent, Bentley introduces polymeric reagents comprising specific atom arrangements between a water-soluble polymer and a reactive group. These polymeric reagents facilitate the formation of polymer-active agent conjugates. By developing new methods and compositions, Bentley's patent plays a crucial role in advancing drug conjugation techniques and drug delivery systems.

Career Highlights:

Throughout his career, Michael David Bentley has contributed significantly to the fields of pharmaceuticals, polymer science, and drug delivery systems. Some notable highlights include:

1. Nektar Therapeutics: Bentley made substantial contributions during his tenure at Nektar Therapeutics, a renowned biopharmaceutical company known for its expertise in drug delivery technologies. His inventions and innovative research played a pivotal role in expanding the company's intellectual property portfolio.

2. Serina Therapeutics, Inc.: Bentley's expertise was also employed at Serina Therapeutics, Inc., another notable player in the pharmaceutical industry. His innovative work in developing chemically modified corticosteroids led to the enhancement of drug delivery systems, thereby revolutionizing medical treatments.

Collaborations:

Michael David Bentley has had the opportunity to work alongside distinguished professionals in the field. Some of his notable coworkers include Xuan Zhao and J Milton Harris.

Conclusion:

With a remarkable portfolio of patents, Michael David Bentley has proven himself as a pioneering figure in the realms of drug delivery systems and polymer science. His inventions, specifically the oligomer-corticosteroid conjugates and polymer derivatives, have the potential to transform pharmaceutical research and revolutionize how drugs are delivered and administered. Bentley's contributions to Nektar Therapeutics and Serina Therapeutics, Inc. further highlight his expertise and impact within the industry. As we eagerly anticipate his future endeavors, Bentley's dedication to innovation continues to inspire aspiring inventors and researchers in the field of pharmaceuticals and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…